Showing results (61-70 of 165) with videos related to
Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B studyGuido Marcucci, Krzysztof Mrózek, Amy S Ruppert, et al.Biorxiv : the Preprint Server for Biology|November 28, 2024
Genotype-immunophenotype relationships in NPM1-mutant AML clonal evolution uncovered by single cell multiomic analysisMorgan Drucker, Darren Lee, Xuan Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology GroupZoAnn E Dreyer, Patricia A Dinndorf, Bruce Camitta, et al.Blood|August 11, 2011
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemiaSebastian Schwind, Guido Marcucci, Jessica Kohlschmidt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology groupNyla A Heerema, Andrew J Carroll, Meenakshi Devidas, et al.Leukemia|February 10, 2019
Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinicallyKrzysztof Mrózek, Ann-Kathrin Eisfeld, Jessica Kohlschmidt, et al.Journal of Pediatric Hematology/Oncology|June 15, 2016
A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1Vilmarie Rodriguez, John Kairalla, Wanda L Salzer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B StudyGuido Marcucci, Kati Maharry, Michael D Radmacher, et al.Leukemia|October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusionsElspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.Blood|September 28, 2006
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)Kirk R Schultz, D Jeanette Pullen, Harland N Sather, et al.Pageof 17